Magnesium for Women: Are There Any Special Considerations?

Magnesium is involved in hundreds of enzymatic reactions, from energy production to muscle contraction and nerve signaling. National survey data suggest many Americans fall short of recommended intakes. For women, magnesium needs and questions shift across the menstrual cycle, pregnancy and menopause. Here is an evidence-based look at what really differs.
How much magnesium women need
The US Recommended Dietary Allowance for magnesium, set by the Institute of Medicine, is 310 mg/day for women aged 19 to 30 and 320 mg/day for women 31 and older. During pregnancy the RDA rises to 350 to 360 mg/day depending on age; during lactation it is 310 to 320 mg/day.
| Group | RDA (mg/day) |
|---|---|
| Women 19–30 | 310 |
| Women 31+ | 320 |
| Pregnancy, 19–30 | 350 |
| Pregnancy, 31–50 | 360 |
| Men 31+ (for comparison) | 420 |
The Tolerable Upper Intake Level for supplemental magnesium is 350 mg/day for adults. This limit applies only to magnesium from supplements and medications, not food, and is set mainly to avoid diarrhea.
Rosanoff, Weaver and Rude (2012) argued that suboptimal magnesium status is common in the US and may be underestimated, partly because serum magnesium is a poor indicator of body stores.
Good food sources include pumpkin seeds, almonds, spinach, black beans, whole grains and dark chocolate.
Menstrual cycle and PMS
Magnesium has been studied for premenstrual symptoms for decades. A small trial by Walker et al. (1998) found that 200 mg of magnesium daily reduced symptoms of fluid retention, such as bloating and breast tenderness, in the second month of supplementation.
A review by Parazzini et al. (2017) concluded that magnesium supplementation may help with premenstrual syndrome and dysmenorrhea (painful periods), though the quality of evidence is modest.
Magnesium may also be combined with vitamin B6 in some PMS studies. Women considering this should be cautious with high-dose B6, which can cause nerve problems with long-term use.
For menstrual migraine, some neurologists recommend magnesium as part of prevention; this should be discussed with a clinician.

Pregnancy, menopause and bone health
During pregnancy, magnesium needs increase slightly. Leg cramps are common, and magnesium is often suggested. However, a Cochrane review (Garrison et al., 2020) found that magnesium is unlikely to provide meaningful prophylaxis for skeletal muscle cramps in older adults, and evidence in pregnancy is mixed.
Intravenous magnesium sulfate is a hospital treatment for preventing seizures in preeclampsia, but this is a completely different use from oral supplements and must never be self-managed.
After menopause, bone health becomes a priority. Magnesium is part of bone mineral, and low intake has been associated with lower bone density in some observational studies, though supplement trials are limited.
Sleep problems increase around menopause. A trial in older adults (Abbasi et al., 2012) found improvements in some sleep measures with magnesium, but most studies are small.
Training and choosing a supplement
Exercise increases magnesium losses through sweat and urine. Nielsen and Lukaski (2006) suggested that athletes may need 10 to 20% more magnesium than sedentary people, particularly during intense training.
Female athletes with low energy availability, restrictive diets or heavy sweating may be at higher risk of low magnesium.
Common forms include:
- Magnesium glycinate: well tolerated, often used for sleep and relaxation;
- Magnesium citrate: well absorbed, may have a mild laxative effect;
- Magnesium oxide: high elemental magnesium but lower absorption;
- Magnesium L-threonate: marketed for cognition, with limited human evidence.
Check the label for elemental magnesium per serving, not the weight of the whole compound.
Safety and interactions
Magnesium supplements are generally safe in healthy people, but those with kidney disease should avoid them unless prescribed.
Magnesium can reduce absorption of certain antibiotics (tetracyclines, fluoroquinolones) and bisphosphonates used for osteoporosis; separate doses by a few hours.
Some medications, including proton pump inhibitors and certain diuretics, can lower magnesium levels.
Very high doses, particularly from magnesium-containing laxatives and antacids, can cause toxicity, with symptoms such as low blood pressure, nausea and irregular heartbeat.
Conclusions from the editorial team
Women need slightly less magnesium than men in absolute terms, but intake often falls short, and needs shift with pregnancy and life stage.
Evidence suggests possible benefits for PMS fluid retention and painful periods, and magnesium supports bone and muscle function. Claims about cramps and sleep are less well supported.
Food first, supplements to fill gaps, and stay within the 350 mg/day supplemental limit unless advised otherwise. Discuss with your clinician during pregnancy or if you take medications.
Related reading on our site: boswellia for women, BCAA for women, and how to choose a quality omega-3.
References
- Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington (DC): National Academy Press; 1997.
- Rosanoff A, Weaver CM, Rude RK. Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutr Rev. 2012;70(3):153–164.
- Walker AF, De Souza MC, Vickers MF, et al. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health. 1998;7(9):1157–1165.
- Parazzini F, Di Martino M, Pellegrino P. Magnesium in the gynecological practice: a literature review. Magnes Res. 2017;30(1):1–7.
- Garrison SR, Korownyk CS, Kolber MR, et al. Magnesium for skeletal muscle cramps. Cochrane Database Syst Rev. 2020;9:CD009402.
- Abbasi B, Kimiagar M, Sadeghniiat K, et al. The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial. J Res Med Sci. 2012;17(12):1161–1169.
- Nielsen FH, Lukaski HC. Update on the relationship between magnesium and exercise. Magnes Res. 2006;19(3):180–189.


